Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

KZR holding history

Kezar Life Sciences, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KZR overviewAll 13F holders of KZRFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of KZR by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−13−100.0%Sold outHolders
Q1 202613$96<0.1%−27−67.5%ReducedHolders
Q4 202540$252<0.1%−316−88.8%ReducedHolders
Q3 2025356$1.39K<0.1%+315+768.3%AddedHolders
Q2 202541$188<0.1%−1,999−98.0%ReducedHolders
Q1 20252,040$9.96K<0.1%−12,800−86.3%ReducedHolders
Q4 202414,840$99.7K<0.1%+14,800+37,186.4%AddedConverted for a 1-for-10 splitHolders
Q3 2024398$308<0.1%−7,019−94.6%ReducedHolders
Q2 20247,417$4.45K<0.1%−64,092−89.6%ReducedHolders
Q1 202471,509$64.5K<0.1%+22,335+45.4%AddedHolders
Q4 202349,174$46.6K<0.1%+15,021+44.0%AddedHolders
Q3 202334,153$40.6K<0.1%−3,159−8.5%ReducedHolders
Q2 202337,312$91.4K<0.1%−59,987−61.7%ReducedHolders
Q1 202397,299$304.5K<0.1%−128,840−57.0%ReducedHolders
Q4 2022226,139$1.59M<0.1%+201,514+818.3%AddedHolders
Q3 202224,625$212.0K<0.1%+22,128+886.2%AddedHolders
Q2 20222,497$21.0K<0.1%−160,416−98.5%ReducedHolders
Q1 2022162,913$2.71M<0.1%+64,791+66.0%AddedHolders
Q4 202198,122$1.64M<0.1%+78,732+406.0%AddedHolders
Q3 202119,390$167.0K<0.1%−47,212−70.9%ReducedHolders
Q2 202166,602$361.0K<0.1%+61,593+1,229.6%AddedHolders
Q1 20215,009$30.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.